Search

Author/Creator Samuel, Douglas

1. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Issue 10075 (25th March 2017)

Authors:
Paramsothy, Sudarshan; Kamm, Michael A; Kaakoush, Nadeem O; Walsh, Alissa J; van den Bogaerde, Johan; Samuel, Douglas; Leong, Rupert W L; Connor, Susan; Ng, Watson; Paramsothy, Ramesh; Xuan, Wei; Lin, Enmoore; Mitchell, Hazel M; Borody, Thomas J
Journal:
Lancet
Issue:
Volume 389:Issue 10075(2017)
Page Start:
1218
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti-TNF Therapeutic Drug Monitoring in Postoperative Crohn's Disease. (27th January 2018)

Authors:
Wright, Emily K; Kamm, Michael A; De Cruz, Peter; Hamilton, Amy L; Selvaraj, Fabiyola; Princen, Fred; Gorelik, Alexandra; Liew, Danny; Prideaux, Lani; Lawrance, Ian C; Andrews, Jane M; Bampton, Peter A; Jakobovits, Simon L; Florin, Timothy H; Gibson, Peter R; Debinski, Henry; Macrae, Finlay A; Sa...
Journal:
Journal of Crohn's and colitis
Issue:
Volume 12:Number 6(2018:Jun.)
Page Start:
653
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. (January 2022)

Authors:
Rubin, David T; Dotan, Iris; DuVall, Aaron; Bouhnik, Yoram; Radford-Smith, Graham; Higgins, Peter D R; Mishkin, Daniel S; Arrisi, Pablo; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Chamberlain-James, Kirsten; Lacey, Stuart; McBride, Jacqueline; Panés, Julian; Abdulkhakov, Rustem; Abu ...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 1(2022)
Page Start:
17
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. (February 2022)

Authors:
Peyrin-Biroulet, Laurent; Hart, Ailsa; Bossuyt, Peter; Long, Millie; Allez, Matthieu; Juillerat, Pascal; Armuzzi, Alessandro; Loftus, Edward V; Ostad-Saffari, Elham; Scalori, Astrid; Oh, Young S; Tole, Swati; Chai, Akiko; Pulley, Jennifer; Lacey, Stuart; Sandborn, William J; Aguilar, Humberto; Ah...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 2(2022)
Page Start:
128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Donor Recruitment for Fecal Microbiota Transplantation. Issue 7 (July 2015)

Authors:
Paramsothy, Sudarshan; Borody, Thomas J.; Lin, Enmoore; Finlayson, Sarah; Walsh, Alissa J.; Samuel, Douglas; van den Bogaerde, Johan; Leong, Rupert W. L.; Connor, Susan; Ng, Watson; Mitchell, Hazel M.; Kaakoush, Nadeem; Kamm, Michael A.
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 7(2015:Jul.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗